Aurothiomalate and hydroxychloroquine inhibit nitric oxide production in chondrocytes and in human osteoarthritic cartilage

Scandinavian Journal of Rheumatology

Volumn 34, Issue 6, 2005, Pages 475-479

  Vuolteenaho, K ^a   Kujala, P ^a   Moilanen, T ^a,b   Moilanen, E ^a,c  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b Coxa Hospital for Joint Replacement ^*  (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LEFLUNOMIDE; METHOTREXATE; NITRIC OXIDE; PENICILLAMINE; SALAZOSULFAPYRIDINE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; CELL CULTURE; CELL IMMORTALIZATION; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANALYSIS OF VARIANCE; ANIMALS; ANTIRHEUMATIC AGENTS; BLOTTING, WESTERN; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; GOLD SODIUM THIOMALATE; HUMANS; HYDROXYCHLOROQUINE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS, KNEE; RNA, MESSENGER;

EID: 30344443349     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740510026797     Document Type: Article

References (21)

1. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998;41:2165-74.
2. Vuolteenaho K, Moilanen T, al-Saffar N, Knowles RG, Moilanen E. Regulation of the nitric oxide production resulting from the glucocorticoid-insensitive expression of iNOS in human osteoarthritic cartilage. Osteoarthritis Cartilage 2001;9:597-605.
3. Sakurai H, Kohsaka H, Liu MF, Higashiyama H, Hirata Y, Kanno K, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995;96:2357-63.
4. Moilanen E, Moilanen T, Knowles R, Charles I, Kadoya Y, al-Saffar N, et al. Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am J Pathol 1997;150:881-7.
5. Farrell AJ, Blake DR, Palmer RM, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
6. Jarvinen TA, Moilanen T, Jarvinen TL, Moilanen E. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage. Mediators Inflamm 1995;4:107-11.
7. Cao M, Westerhausen-Larson A, Niyibizi C, Kavalkovich K, Georgescu HI, Rizzo CF, et al. Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target. Biochem J 1997;324:305-10.
8. Hashimoto S, Setareh M, Ochs RL, Lotz M. Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 1997;40:1749-55.
9. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
10. Studer RK, Georgescu HI, Miller LA, Evans CH. Inhibition of transforming growth factor beta production by nitric oxide-treated chondrocytes: implications for matrix synthesis. Arthritis Rheum 1999;42:248-57.
11. Vuolteenaho K, Moilanen T, Hamalainen M, Moilanen E. Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilage. Role of endogenous IL-1 inhibitors. Scand J Rheumatol 2003;32:19-24.
12. McCartney-Francis N, Allen JB, Mizel DE, Albina JE, Xie QW, Nathan CF, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993;178:749-54.
13. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86.
14. van Beuningen HM, Stoop R, Buma P, Takahashi N, van der Kraan PM, van den Berg WB. Phenotypic differences in murine chondrocyte cell lines derived from mature articular cartilage. Osteoarthritis Cartilage 2002;10:977-86.
15. Korhonen R, Kankaanranta H, Lahti A, Lahde M, Knowles RG, Moilanen E. Bi-directional effects of the elevation of intracellular calcium on the expression of inducible nitric oxide synthase in J774 macrophages exposed to low and to high concentrations of endotoxin. Biochem J 2001;354:351-8.
16. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
17. Kleinert H, Schwarz PM, Forstermann U. Regulation of the expression of inducible nitric oxide synthase. Biol Chem 2003;384:1343-64.
18. Yamashita M, Niki H, Yamada M, Mue S, Ohuchi K. Induction of nitric oxide synthase by lipopolysaccharide and its inhibition by auranofin in RAW 264.7 cells. Eur J Pharmacol 1997;338:151-8.
19. Hrabak A, Sefrioui H, Vercruysse V, Temesi A, Bajor T, Vray B. Action of chloroquine on nitric oxide production and parasite killing by macrophages. Eur J Pharmacol 1998;354:83-90.
20. Gerber RC, Paulus HE, Bluestone R, Pearson CM. Clinical response and serum gold levels in chrysotherapy. Lack of correlation. Ann Rheum Dis 1972;31:308-10.
21. Tett SE, Cutler DJ, Day RO, Brown KF. Bioavailability of hydroxychloroquine tablets in healthy volunteers. Br J Clin Pharmacol 1989;27:771-9.